Abbott's vision is that 'every sporting event, urgent care clinic, ambulance, and school' will have on hand the blood test system for traumatic brain injury.
Manny Johnson Analysts view the $150 million acquisition of Simplify Medical as a positive move for NuVasive.
Rockaway, N.J.-based electroCore has finished enrollment for SAVIOR-1, a trial set to evaluate the effect of the gammaCore Sapphire on COVID-19 symptoms.
TransEnterix is changing its name to Asensus Surgical and plans to introduce 'performance-guided' surgery.
FDA issued a new suite of guidances for developers of COVID-19 tests, vaccines, and therapeutics to address variants of the virus.
The federal government presents a lucrative and important market opportunity for medical device companies.
A webinar series explores how sensors and electronics can be used for demanding medtech applications.
FDA’s Jeff Shuren, MD, and Timothy Stenzel, MD, discussed the flaws of the antibody testing guidance in a recently published editorial in The New England ...
Guardant Health has launched a blood-only liquid biopsy test for the detection of residual and recurrent colorectal cancer.
The Irvine, CA-based company has raised $41 million in a public offering to fund a pivotal trial for the VenoValve.
Longeviti Neuro Solutions co-founder and CEO, Jesse Christopher stops by Let’s Talk Medtech to discuss the firm; its products; and being at the helm of a ...
The COVID-19 pandemic created a number of challenges, including cybersecurity risks. Ahead of the next crisis, medtech needs a proactive and inherent approach ...